CoChat

MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells

Open access
Liang, Hui, Xu, Yisong, Zhang, Qiang, Yang, Yu, Mou, Yueyang, Gao, Yingchun, Chen, Rui, Chen, Chao, Dai, Penggao · 2019 · Artificial Cells, Nanomedicine, and Biotechnology

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Oxaliplatin resistance limits the efficiency of treatment for colorectal cancer (CRC). Studies have shown that abnormal expression of microRNAs (miRNAs) were associated with tumorigenesis, cancer development and chemoresistance. The purpose of this study was to identify potential miRNAs related to oxaliplatin resistance in CRC cells. In this work, using small RNA sequencing (small RNA-Seq) and transcriptome sequencing (RNA-Seq), we found that down-regulated miR-483-3p was concurrent with up-regulated FAM171B in oxaliplatin-resistant colorectal cancer cell line HCT116/L as compared with its parental cell line HCT116. Transient transfection of miR-483-3p mimics markedly decreased the levels of FAM171B and restored oxaliplatin responsiveness of HCT116/L cells, and this alteration enhanced cell apoptosis and weakened cell migration. Whereas miR-483-3p inhibitor dramatically promoted the expression of FAM171B and enhanced oxaliplatin resistance of HCT116 cells by repressing cell apoptosis. Furthermore, knockdown of FAM171B in HCT116/L cells could also sensitize its reaction of the treatment with oxaliplatin, which was verified by the reduced cell migration. These findings demonstrate that FAM171B is a functional target of miR-483-3p in the regulation of oxaliplatin resistance in human CRC cells.

Overview

Integrity signals

Registry

Crossref · 10.1080/21691401.2019.1569530

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

See all 45

Metadata

Authors
Liang, H., Xu, Y., Zhang, Q., Yang, Y., Mou, Y., Gao, Y., Chen, R., Chen, C., & Dai, P.
Affiliations
  • Northwest University (US)
  • National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University
Corresponding author
Dai, Penggao
Venue
Artificial Cells, Nanomedicine, and Biotechnology
Published
2019-03-12
Volume
47
Issue
1
Pages
725-736
ISSN
  • 2169-1401 (ISSN-L)
  • 2169-141X
OpenAlex
W2921842373
Cited by
43
References
40
Citations by year
2026: 2 · 2025: 6 · 2024: 1 · 2023: 7 · 2022: 2 · 2021: 12 · 2020: 8 · 2019: 5
FWCI
2.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Artificial Cells Nanomedicine and Biotechnology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Shaanxi Natural Science Foundation (2018JZ3007)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
miR-483-3p, oxaliplatin resistance, colorectal cancer, chemoresistance, microRNA target regulation, apoptosis, cell migration
MeSH terms
Oxaliplatin, Antineoplastic Agents, Cell Movement, Humans, Membrane Proteins, Neoplasm Proteins, Colorectal Neoplasms, Gene Expression, Gene Expression Regulation, Neoplastic, Apoptosis, Drug Resistance, Neoplasm, Gene Expression Profiling, MicroRNAs, HCT116 Cells, Cell Line, Tumor, Cell Proliferation, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. https://app.cochat.ai/papers/10.1080/21691401.2019.1569530
The paper
Liang, H., Xu, Y., Zhang, Q., Yang, Y., Mou, Y., Gao, Y., Chen, R., Chen, C., & Dai, P. (2019). MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Artificial Cells, Nanomedicine, and Biotechnology. https://doi.org/10.1080/21691401.2019.1569530

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.